Results 11 to 20 of about 3,744 (163)

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry. [PDF]

open access: yesBr J Haematol, 2021
Summary Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608).
Borjas Howard J   +10 more
europepmc   +2 more sources

[Pulmonary Embolism]. [PDF]

open access: yesOpen Respir Arch
Resumen: La tromboembolia de pulmón (TEP), la forma más grave de presentación de la enfermedad tromboembólica venosa (ETV), constituye actualmente un problema sanitario de primer orden, por su elevado impacto en términos de morbimortalidad, costes y ...
Barca-Hernando M   +5 more
europepmc   +2 more sources

Enfermedad tromboembólica venosa en poblaciones específicas: mucho por aprender

open access: yesGalicia Clínica, 2021
La enfermedad tromboembólica venosa (ETV), que incluye principalmente el embolismo pulmonar (EP) y la trombosis venosa profunda (TVP) de extremidades inferiores, es una causa importante de mortalidad, especialmente en grupos poblacionales concretos como ...
Lucía Ordieres-Ortega   +1 more
doaj   +1 more source

Comportamiento de la enfermedad tromboembólica venosa en un centro hospitalario de la ciudad de Popayán, Colombia

open access: yesRevista Salud Bosque, 2021
Introducción: La enfermedad tromboembólica venosa es la tercera causa de enfermedad cardiovascular, siendo un problema de salud pública debido a la carga de la enfermedad y los costos de la misma.
Juan David Guzmán Sandoval   +3 more
doaj   +1 more source

Safety of the pulmonary embolism rule‐out criteria rule: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry

open access: yesAcademic Emergency Medicine, Volume 30, Issue 9, Page 935-945, September 2023., 2023
Abstract Background The diagnostic strategy for pulmonary embolism (PE) includes a D‐dimer test when PE probability is low or intermediate, but false‐positive D‐dimer results are frequent and can result in an unnecessary computed tomography pulmonary angiogram.
Perrine Truong   +204 more
wiley   +1 more source

Validation of Echocardiographic Measurements in Patients with Pulmonary Embolism in the RIETE Registry. [PDF]

open access: yesTH Open
Background In acute pulmonary embolism (PE), echocardiographic identification of right ventricular (RV) dysfunction will inform prognostication and clinical decision-making. Registro Informatizado Enfermedad TromboEmbolica (RIETE) is the world'
Lyhne MD   +11 more
europepmc   +2 more sources

Registro Institucional de Enfermedad Tromboembólica (RIET)

open access: yesRevista del Hospital Italiano de Buenos Aires, 2021
.
María F. Grande Ratti   +1 more
doaj   +1 more source

Failure rate of the pulmonary embolism rule-out criteria rule for adults 35 years or younger: Findings from the RIETE Registry. [PDF]

open access: yesAcad Emerg Med
Abstract Background The use of a computed tomography pulmonary angiogram to diagnose pulmonary embolism (PE) has increased, leading not only to higher PE diagnoses but also to overdiagnosis and unnecessary radiation exposure, even in young patients despite a lower PE incidence.
Jossein T   +10 more
europepmc   +2 more sources

Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

open access: yesBritish Journal of Haematology, Volume 201, Issue 5, Page 971-981, June 2023., 2023
Summary Predictive tools for major bleeding (MB) using machine learning (ML) might be advantageous over traditional methods. We used data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) to develop ML algorithms to identify patients with venous thromboembolism (VTE) at increased risk of MB during the first 3 months of ...
Damián Mora   +207 more
wiley   +1 more source

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

open access: yesResearch and Practice in Thrombosis and Haemostasis, Volume 6, Issue 4, May 2022., 2022
Abstract Background Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. Objectives The objective of the RIETECAT study was to compare the long‐term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active ...
Javier Trujillo‐Santos   +182 more
wiley   +1 more source

Home - About - Disclaimer - Privacy